CTOs on the Move

Wilcox Health System

www.wilcoxhealth.org

 
Wilcox Health System is a Lihue, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Welch Allyn Inc.

Welch Allyn Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Skaneateles Falls, NY. To find more information about Welch Allyn Inc., please visit www.welchallyn.com

Medtronic Navigation

Medtronic Navigation is a Louisville, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

City of Melbourne FL

Terms Of Use Please be aware that when engaging with the City of Melbourne, Florida, through its social media pages, you are agreeing to the following terms of use: 1.) The Citys social media sites are not monitored at all times. Do NOT use thes...

QuadraMed

Quadramed is an Electronic Document Management solution for your healthcare network that acts as a repository for downloaded and scanned documents.

Accord BioPharma

Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.